Grow Therapy, a New York-based company specializing in mental healthcare solutions, recently secured $150 million in a Series D funding round led by TCV and Growth Equity at Goldman Sachs. Having raised $328 million in funding to date, Grow Therapy’s platform delivers in-person and online therapy and psychiatric care through its network of 26,000 providers.
The company has served nearly 2 million people nationwide in the past five years and has facilitated 10 million therapy and medication management appointments since its inception. Grow Therapy has also made various growth moves since its Series C in April 2024, including advancing its provider tools, launching new outcomes measurement systems and expanding insurance coverage to over 125 partners.
“Grow has built alliances and capabilities that deliver win-win-win results for clients, providers and all of our other partners with a stake in mental healthcare,” Jake Cooper, Grow Therapy’s CEO and co-founder, said in a statement. “This Series D reflects investor confidence in Grow’s ability to execute a high-impact strategy and continue making mental healthcare more accessible, effective and connected.”
Equipped with its fresh capital, Grow Therapy plans to accelerate its work with employers to improve workplace mental health benefits, extend its platform to health systems such as Circle Medical and further deepen its platform integrations in 2026.
